First Fiduciary Investment Counsel, Inc. Pfizer Inc Transaction History

First Fiduciary Investment Counsel, Inc.

$482 Million
Q1 2024

A detailed history of First Fiduciary Investment Counsel, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, First Fiduciary Investment Counsel, Inc. holds 252,011 shares of PFE stock, worth $6.99 Million. This represents 1.45% of its overall portfolio holdings.

Number of Shares

252,011

Previous 255,497 1.36%

Holding current value

$6.99 Million

Previous $7.36 Million 4.93%

% of portfolio

1.45%

Previous 1.62%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$25.89 - $29.73 $90,252 - $103,638	-3,486 Reduced 1.36%	252,011 $6.99 Million
Q4 2023 Feb 02, 2024	SELL	$26.13 - $33.94 $269,739 - $350,362	-10,323 Reduced 3.88%	255,497 $7.36 Million
Q3 2023 Nov 07, 2023	BUY	$32.09 - $37.51 $200,626 - $234,512	6,252 Added 2.41%	265,820 $8.82 Million
Q2 2023 Jul 21, 2023	BUY	$36.12 - $41.79 $1.51 Million - $1.75 Million	41,816 Added 19.2%	259,568 $9.52 Million
Q1 2023 May 04, 2023	BUY	$39.39 - $51.28 $509,903 - $663,819	12,945 Added 6.32%	217,752 $8.88 Million

Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $116,774 - $152,436	-2,797 Reduced 1.35%	204,807 $10.5 Million
Q3 2022 Oct 31, 2022	SELL	$43.76 - $53.42 $58,944 - $71,956	-1,347 Reduced 0.64%	207,604 $9.09 Million
Q2 2022 Jul 19, 2022	SELL	$46.53 - $55.17 $144,196 - $170,971	-3,099 Reduced 1.46%	208,951 $11 Million
Q1 2022 Apr 21, 2022	SELL	$45.75 - $56.69 $10 Million - $12.4 Million	-219,382 Reduced 50.85%	212,050 $11 Million
Q4 2021 Jan 14, 2022	SELL	$41.32 - $61.25 $1.17 Million - $1.74 Million	-28,327 Reduced 6.16%	431,432 $25.5 Million
Q3 2021 Oct 07, 2021	SELL	$39.25 - $50.42 $1.15 Million - $1.48 Million	-29,257 Reduced 5.98%	459,759 $19.8 Million
Q2 2021 Jul 29, 2021	SELL	$35.91 - $40.68 $1.58 Million - $1.79 Million	-44,032 Reduced 8.26%	489,016 $19.2 Million
Q1 2021 May 12, 2021	SELL	$33.49 - $37.77 $979,883 - $1.11 Million	-29,259 Reduced 5.2%	533,048 $19.3 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $164,739 - $209,480	-4,922 Reduced 0.87%	562,307 $20.7 Million
Q3 2020 Nov 18, 2020	SELL	$31.75 - $37.25 $268,255 - $314,725	-8,449 Reduced 1.47%	567,229 $20.8 Million
Q2 2020 Aug 10, 2020	BUY	$30.12 - $36.54 $31,927 - $38,732	1,060 Added 0.18%	575,678 $18.8 Million
Q1 2020 May 12, 2020	SELL	$27.03 - $38.62 $55,384 - $79,132	-2,049 Reduced 0.36%	574,618 $18.8 Million
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $1.57 Million - $1.79 Million	47,819 Added 9.04%	576,667 $22.6 Million
Q3 2019 Nov 15, 2019	BUY	$32.49 - $42.13 $578,646 - $750,335	17,810 Added 3.49%	528,848 $19 Million
Q2 2019 Jul 25, 2019	SELL	$36.98 - $41.52 $2.41 Million - $2.71 Million	-65,221 Reduced 11.32%	511,038 $22.1 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $380,887 - $418,468	-10,157 Reduced 1.73%	576,259 $24.5 Million
Q4 2018 Feb 04, 2019	BUY	$38.47 - $43.86 $32,699 - $37,281	850 Added 0.15%	586,416 $25.6 Million
Q3 2018 Oct 29, 2018	SELL	$34.47 - $41.81 $1.59 Million - $1.92 Million	-45,985 Reduced 7.28%	585,566 $25.8 Million
Q2 2018 Aug 15, 2018	SELL	$32.98 - $35.16 $350,940 - $374,137	-10,641 Reduced 1.66%	631,551 $22.9 Million
Q1 2018 May 03, 2018	BUY	$31.91 - $37.02 $87,082 - $101,027	2,729 Added 0.43%	642,192 $22.8 Million
Q4 2017 Feb 20, 2018	SELL	$33.26 - $35.29 $619,800 - $657,629	-18,635 Reduced 2.83%	639,463 $23.2 Million
Q3 2017 Nov 20, 2017	BUY	$31.0 - $34.15 $34,410 - $37,906	1,110 Added 0.17%	658,098 $23.5 Million
Q2 2017 Aug 15, 2017	BUY	N/A	656,988	656,988 $22.1 Million

Others Institutions Holding PFE

# of Institutions

3,164

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $156B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Fiduciary Investment Counsel, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Fiduciary Investment Counsel, Inc. with notifications on news.

Account

First Fiduciary Investment Counsel, Inc. Pfizer Inc Transaction History